Table 1 The clinical features of the patients with pancreatic signet ring cell carcinoma (PSRCC)
Variables | Available data-N (%) | N (%) |
|---|---|---|
Age at diagnosis | 585 (100) | |
67.0 [59.0, 75.0] | ||
< =67 | 300 (51.3) | |
> 67 | 285 (48.7) | |
Sex | ||
Female | 585 (100) | 260 (44.4) |
Male | 325 (55.6) | |
Race | 583 (99.7) | |
White | 482 (82.7) | |
Black | 62 (10.6) | |
Other | 39 (6.7) | |
Year of diagnosis | 585 (100) | |
2000–2009 | 323 (55.2) | |
2010–2018 | 262 (44.8) | |
Marital status at diagnosis | 560 (95.7) | |
Married | 331 (59.1) | |
Unmarried | 229 (40.9) | |
Differentiation grade | 280 (47.9) | |
I/II | 34 (12.1) | |
III/IV | 246 (87.9) | |
Tumor size | 383 (65.5) | |
< =4 | 216 (56.4) | |
> 4 | 167 (43.6) | |
Primary site | 462 (79.0) | |
Head | 273 (46.7) | |
Body | 60 (10.3) | |
Tail | 85 (14.5) | |
Other | 44 (7.5) | |
Regional nodes status | 578 (98.8) | |
Negative | 41 (7.1) | |
Positive | 88 (15.2) | |
No nodes examined | 449 (77.7) | |
Summary stage | 566 (96.8) | |
Localized/Regional | 170 (30.0) | |
Distant | 396 (70.0) | |
Surgery | 581 (99.3) | |
Yes | 100 (17.2) | |
No | 481 (82.8) | |
Chemotherapy | 585 (100) | |
Yes | 263 (45.0) | |
No/Unknown | 322 (55.0) | |
Radiation | 585 (100) | |
Yes | 80 (13.7) | |
No/Unknown | 505 (86.3) | |